Genome Medicine · 2014 · 25 citations · 8 references
MedicineMolecular GeneticsOncologyCancer GeneticsMolecular OncologyNeoplasiaCancer GenomicsCancer Molecular DiagnosticsCirculating Tumor Dna AnalysisDna SequencingSolid Tumor OncologySomatic Variant InterpretationBlood Sample CollectionCirculating Cell-free Dna AnalysisCirculating Tumor Dna DetectionCirculating Tumor Dna SequencingCirculating Tumor Dna TestingSomatic Genomic AlterationsSomatic MutationsTumor Mutation Detection
Assessment of somatic genomic alterations from tumors can now be performed by sequencing circulating tumor DNA from the cell-free component of blood. This procedure, which identifies tumor-derived somatic mutations from a simple blood sample, circumvents the need for tumor tissue. A recent study highlights the promise of circulating tumor DNA to guide therapeutic decisions in a variety of solid tumors for both clinical and investigative purposes, as well as providing a tool for the early detection of cancer.
8
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
Chetan Bettegowda, Mark Sausen, Rebecca Leary et al. · Science Translational Medicine · 2014 · 5.1K citations · Full text
Circulating mutant DNA to assess tumor dynamics
Frank Diehl, Kerstin Schmidt, Michael A. Choti et al. · Nature Medicine · 2008 · 2.7K citations · Full text
An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
Aaron M. Newman, Scott V. Bratman, Jacqueline To et al. · Nature Medicine · 2014 · 2.3K citations · Full text
Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
Sarah‐Jane Dawson, Dana W.Y. Tsui, Muhammed Murtaza et al. · New England Journal of Medicine · 2013 · 2.2K citations · Full text
The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers
Luis A. Díaz, Richard T. Williams, Jian Wu et al. · Nature · 2012 · 1.7K citations · Full text